Neurocentrx Pharma

Neurocentrx is a clinical-stage biopharmaceutical company developing the world’s first abuse-deterrent, immediate-release oral ketamine therapy designed for both in-clinic and at-home care settings. Headquartered in Edinburgh, Scotland, with global research collaborations and operations in Australia... Read more